Management of Atrial Fibrillation: Focus on Rate Versus Rhythm Control

被引:1
作者
Schapira, Jay N. [1 ,2 ]
Voroshilovsky, Olga [1 ]
机构
[1] Cedars Sinai Med Ctr, Dept Cardiol, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
Anticoagulation; Atrial fibrillation; Rate control; Rhythm control; MAINTAINING SINUS RHYTHM; ANTITHROMBOTIC THERAPY; ANTIARRHYTHMIC-DRUGS; COMPARATIVE EFFICACY; RISK; STROKE; DRONEDARONE; AMIODARONE; STRATEGIES; PHYSICIANS;
D O I
10.3909/ricm0504
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation (AF) is the most common cardiac arrhythmia in adults and accounts for approximately one-third of all arrhythmias requiring admission to the hospital. Treatment strategies are determined by the classification of AF, whether paroxysmal or persistent, as well as numerous patient-specific cardiac and medical considerations (eg, pre-existing congestive heart failure or previous myocardial infarction). Thromboembolic risk also influences whether patients are treated with antiplatelet or anticoagulant medications. Several large clinical trials have deemed both rate and rhythm control acceptable treatment strategies for AF. Additionally, nonpharmacologic approaches such as surgical and electroablative options also exist. The clinician must exercise sound clinical judgment when deciding which treatment approach is best suited for a particular patient. [Rev Cardiovasc Med 2010;11(1):1-12 doi: 10.3909/ricm0504] (C) 2010 MedReview (R), LLC
引用
收藏
页码:1 / 12
页数:12
相关论文
共 35 条
[1]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[2]   ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents [J].
Bhatt, Deepak L. ;
Scheiman, James ;
Abraham, Neena S. ;
Antman, Elliott M. ;
Chan, Francis K. L. ;
Furberg, Curt D. ;
Johnson, David A. ;
Mahaffey, Kenneth W. ;
Quigley, Eamonn M. ;
Harrington, Robert A. ;
Bates, Eric R. ;
Bridges, Charles R. ;
Eisenberg, Mark J. ;
Ferrari, Victor A. ;
Hlatky, Mark A. ;
Kaul, Sanjay ;
Lindner, Jonathan R. ;
Moliterno, David J. ;
Mukherjee, Debabrata ;
Schofield, Richard S. ;
Rosenson, Robert S. ;
Stein, James H. ;
Weitz, Howard H. ;
Wesley, Deborah J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (18) :1502-1517
[3]  
BIALY D, 1992, J AM COLL CARDIOL, V19, P41
[4]   HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up [J].
Calkins, Hugh ;
Brugada, Josep ;
Packer, Douglas L. ;
Cappato, Riccardo ;
Chen, Shih-Ann ;
Crijns, Harry J. G. ;
Damiano, Ralph J., Jr. ;
Davies, D. Wyn ;
Haines, David E. ;
Haissaguerre, Michel ;
Iesaka, Yoshito ;
Jackman, Warren ;
Jais, Pierre ;
Kottkamp, Hans ;
Kuck, Karl Heinz ;
Lindsay, Bruce D. ;
Marchlinski, Francis E. ;
McCarthy, Patrick M. ;
Mont, J. Lluis ;
Morady, Fred ;
Nademanee, Koontawee ;
Natale, Andrea ;
Pappone, Carlo ;
Prystowsky, Eric ;
Raviele, Antonio ;
Ruskin, Jeremy N. ;
Shemin, Richard J. .
HEART RHYTHM, 2007, 4 (06) :816-861
[5]   Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation - The Strategies of Treatment of Atrial Fibrillation (STAF) study [J].
Carlsson, J ;
Miketic, S ;
Windeler, J ;
Cuneo, A ;
Haun, S ;
Micus, S ;
Walter, S ;
Tebbe, U .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1690-1696
[6]   Epidemiology and natural history of atrial fibrillation: Clinical implications [J].
Chugh, SS ;
Blackshear, JL ;
Shen, WK ;
Hammill, SC ;
Gersh, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :371-378
[7]   Functional status in rate- versus rhythm-control strategies for atrial fibrillation - Results of the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) functional status substudy [J].
Chung, MK ;
Shemanski, L ;
Sherman, DG ;
Greene, HL ;
Hogan, DB ;
Kellen, JC ;
Kim, SG ;
Martin, LW ;
Rosenberg, Y ;
Wyse, DG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) :1891-1899
[8]   New Horizons in antiarrhythmic therapy: Will novel agents overcome current deficits? [J].
Conway, Emily ;
Musco, Simone ;
Kowey, Peter R. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (6A) :12H-19H
[9]   Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study [J].
Corley, SD ;
Epstein, AE ;
DiMarco, JP ;
Domanski, MJ ;
Geller, N ;
Greene, HL ;
Josephson, RA ;
Kellen, JC ;
Klein, RC ;
Krahn, AD ;
Mickel, M ;
Mitchell, LB ;
Nelson, JD ;
Rosenberg, Y ;
Schron, E ;
Shemanski, L ;
Waldo, AL ;
Wyse, DG .
CIRCULATION, 2004, 109 (12) :1509-1513
[10]   Dronedarone: An amiodarone analog for the treatment of atrial fibrillation and atrial flutter [J].
Dale, Krista M. ;
White, C. Michael .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) :599-605